AUD 0.08
(-3.53%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 651.54 Thousand AUD | -64.22% |
2023 | 1.82 Million AUD | 70.87% |
2022 | 1.06 Million AUD | -21.81% |
2021 | 1.36 Million AUD | 69.77% |
2020 | 802.85 Thousand AUD | 111.44% |
2019 | 379.71 Thousand AUD | 157.64% |
2018 | 147.37 Thousand AUD | 16.52% |
2017 | 126.48 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 701.07 Thousand AUD | 0.0% |
2024 Q4 | 651.54 Thousand AUD | 0.0% |
2024 FY | 651.54 Thousand AUD | -64.22% |
2023 FY | 1.82 Million AUD | 70.87% |
2023 Q2 | 1.24 Million AUD | 0.0% |
2023 Q4 | 1.82 Million AUD | 0.0% |
2022 Q4 | 1.06 Million AUD | 0.0% |
2022 FY | 1.06 Million AUD | -21.81% |
2022 Q2 | 1.05 Million AUD | 0.0% |
2021 Q2 | 643.01 Thousand AUD | 0.0% |
2021 FY | 1.36 Million AUD | 69.77% |
2021 Q4 | 1.36 Million AUD | 0.0% |
2020 Q4 | 802.85 Thousand AUD | 0.0% |
2020 FY | 802.85 Thousand AUD | 111.44% |
2020 Q2 | 547.15 Thousand AUD | 0.0% |
2019 Q4 | 379.71 Thousand AUD | 0.0% |
2019 Q2 | 406.97 Thousand AUD | 0.0% |
2019 FY | 379.71 Thousand AUD | 157.64% |
2018 Q4 | 147.37 Thousand AUD | 0.0% |
2018 FY | 147.37 Thousand AUD | 16.52% |
2018 Q2 | 118.91 Thousand AUD | 0.0% |
2017 FY | 126.48 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Australian Clinical Labs Limited | 415.29 Million AUD | 99.843% |
BCAL Diagnostics Limited | 3.67 Million AUD | 82.281% |
Genetic Signatures Limited | 6.18 Million AUD | 89.464% |
Genetic Technologies Limited | 4.35 Million AUD | 85.043% |
Healius Limited | 1.94 Billion AUD | 99.966% |
Imagion Biosystems Limited | 8.37 Million AUD | 92.22% |
Integral Diagnostics Limited | 442.56 Million AUD | 99.853% |
INOVIQ Ltd | 1.71 Million AUD | 62.106% |
Microba Life Sciences Limited | 16.82 Million AUD | 96.127% |
Monash IVF Group Limited | 261.81 Million AUD | 99.751% |
Sonic Healthcare Limited | 6.75 Billion AUD | 99.99% |